| Announce Date | 11/04/2025 |
| EPS Normalized Actual | $0.33 (Beat by $0.11) |
| EPS GAAP Actual | $0.33 (Beat by $0.11) |
| Revenue Actual | $0.240172B |
| Revenue Surprise | Beat by $240.172M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $0.34667 |
| EPS GAAP Estimate | $0.34667 |
| Revenue Estimate | $0.212735667B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2026 | 0.3 | 47.9 | 0.29574 | 0.30587 | 1 |
| Dec 2025 | 0.28 | 51.32 | 0.28 | 0.28 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.0214 | 0.19473 | 0.240172B | 14.23% | 91.27M |
| FQ2 2025 (Jun 2025) | -0.18 | -0.18 | 0.167945B | 18.72% | 167.95M |
| FQ1 2025 (Mar 2025) | -0.0008 | -0.0008 | 0.179721B | 14.53% | 179.72M |
| FQ4 2024 (Dec 2024) | -0.46 | -0.46 | 0B | -INF% | 0M |
| FQ3 2024 (Sep 2024) | 0.42 | 0.42 | 0.206005B | 14.57% | 206.01M |
| FQ2 2024 (Jun 2024) | -0.46 | -0.46 | 0.136499B | 8.57% | 136.5M |
| FQ1 2024 (Mar 2024) | -0.0746 | -0.0746 | 0.153614B | 6.65% | 153.61M |
| FQ4 2023 (Dec 2023) | -0.51 | -0.51 | 0.125362B | 100% | 125.36M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
0.34667
Consensus Revenue Estimates
0.212735667B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | -0.15 | -- | -0.15155 | -0.14844 | 1 |
| FQ3 2027 (Sep 2027) | 0.51 | -- | 0.49899 | 0.52101 | 1 |
| FQ2 2027 (Jun 2027) | -0.12 | -- | -0.12259 | -0.11741 | 1 |
| FQ1 2027 (Mar 2027) | 0 | -- | 0 | 0 | 0 |
| FQ4 2026 (Oct 2026) | 0.49 | -- | 0.4432 | 0.5213 | 0 |
| FQ3 2026 (Jul 2026) | -0.06 | 135.67 | -0.06383262 | -0.05426918 | 0 |
| FQ2 2026 (Jun 2026) | -0.07 | -157.14 | -0.0725085 | -0.06807121 | 0 |
| FQ1 2026 (Mar 2026) | 0.09 | 100.89 | 0.08752013 | 0.09322522 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.19B | -- | 0.19B | 0.19B | 1 |
| FQ3 2027 (Sep 2027) | 0.26B | -- | 0.26B | 0.27B | 1 |
| FQ2 2027 (Jun 2027) | 0.18B | -- | 0.17B | 0.18B | 1 |
| FQ1 2027 (Mar 2027) | 0.18B | -- | 0.18B | 0.19B | 1 |
| FQ4 2026 (Oct 2026) | 0.23B | -- | 0.21B | 0.24B | 1 |
| FQ3 2026 (Jul 2026) | 0.17B | -41.03 | 0.16B | 0.18B | 1 |
| FQ2 2026 (Jun 2026) | 0.16B | -4.18 | 0.16B | 0.17B | 1 |
| FQ1 2026 (Mar 2026) | 0.17B | -8.33 | 0.16B | 0.17B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
2
EPS # of Misses
6
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
0
Revenue # of in-lines
1
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.17333 | 0.0214 | 0.19473 | 909.95% |
| FQ2 2025 (Jun 2025) | -0.18 | -0.18 | 100% | |
| FQ1 2025 (Mar 2025) | -0.0008 | -0.0008 | 100% | |
| FQ4 2024 (Dec 2024) | -0.46 | -0.46 | 100% | |
| FQ3 2024 (Sep 2024) | 0.42 | 0.42 | 100% | |
| FQ2 2024 (Jun 2024) | -0.46 | -0.46 | 100% | |
| FQ1 2024 (Mar 2024) | -0.0746 | -0.0746 | 100% | |
| FQ4 2023 (Dec 2023) | -0.51 | -0.51 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.15B | $0.24B | $91.27M | 38% |
| FQ2 2025 (Jun 2025) | $0B | $0.17B | $167.95M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0.18B | $179.72M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0B | $0M | NAN% |
| FQ3 2024 (Sep 2024) | $0B | $0.21B | $206.01M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.14B | $136.5M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.15B | $153.61M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.13B | $125.36M | 100% |